Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy.
Sun Hee HeoEungu KangYoon-Myung KimHeounjeong GoKyung Yong KimJae Yong JungMinji KangGu-Hwan KimJae-Min KimIn-Hee ChoiJin-Ho ChoiSung-Chul JungRobert J DesnickHan-Wook YooBeom-Hee LeePublished in: Journal of medical genetics (2017)
These results indicated that C3-mediated complement activation might be altered in Fabry disease and ERT might promote its stabilisation.